Cargando…
Are we closer to having drugs to treat muscle wasting disease?
The two most common muscle wasting diseases in adults are sarcopenia and cachexia. Despite differences in their pathophysiology, it is believed that both conditions are likely to respond to drugs that increase muscle mass and muscle strength. The current gold standard in this regard is exercise trai...
Autores principales: | Morley, John E., von Haehling, Stephan, Anker, Stefan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053564/ https://www.ncbi.nlm.nih.gov/pubmed/24865381 http://dx.doi.org/10.1007/s13539-014-0149-7 |
Ejemplares similares
-
From muscle wasting to sarcopenia and myopenia: update 2012
por: von Haehling, Stephan, et al.
Publicado: (2012) -
Muscle wasting disease: a proposal for a new disease classification
por: Anker, Stefan D., et al.
Publicado: (2014) -
Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention
por: Anker, Stefan D., et al.
Publicado: (2014) -
Once I get on a puzzle, I can't get off: Cachexia and wasting in 2018
por: von Haehling, Stephan, et al.
Publicado: (2018) -
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2010)